Comparison of Esophageal and Central Venous Pressure for Estimating Transpulmonary Pressure Changes (PPLproject)

June 21, 2020 updated by: Federico Franchi, University of Siena

Estimating the Transpulmonary Pressure From the Central Venous Pressure in Mechanically Ventilated Patients With Respiratory Failure

Central venous pressure (CVP) is characterized by a low-frequency pleural-dependent as well as a high-frequency cardiac pulsatile component. The aim of the study is to compare the low-frequency component of CVP with the esophageal pressure (Pes), as surrogate of pleural pressure, to estimate trans-pulmonary pressure (PL).

Study Overview

Detailed Description

The investigators will enroll mechanically ventilated patients admitted to the intensive care unit with the diagnosis of respiratory failure monitored with a dedicated nasogastric catheter and a central venous catheter for measuring Pes and CVP, respectively. Electrocardiogram trace, Pes, CVP and airway pressure (Paw) will be recorded at the end of inspiratory and expiratory pauses. The CVP waveforms will be analyzed off-line using a dedicated low-pass digital filter to obtain the low-frequency component of CVP (filtered CVP, fCVP). Paw, Pes and fCVP will be used to calculate PL using transpulmonary driving pressure formula (PL-Pes and PL-fCVP, respectively). The PL values obtained with fCVP and Pes will be compared to assess the correlation of the two methods.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Siena, Italy, 53100
        • Azienda Ospedaliera Universitaria Senese

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients admitted to ICU treated with mechanical ventilation.

Description

Inclusion Criteria:

  • adult patients receiving invasive mechanical ventilation
  • diagnosis of acute respiratory failure (defined as the ratio of partial oxygen pressure and fraction of inspired oxygen below 200 mmHg)
  • esophageal balloon catheter
  • central venous catheter

Exclusion Criteria:

  • age under 18 years old
  • Hemodynamic instability
  • Esophageal diseases (varices, stenosis..)
  • Refusal of the patient
  • evidence of active air leak from the lung (pneumothorax, pneumomediastinum, existing chest tube....)
  • history of lung/abdominal surgery
  • pregnancy
  • severe coagulopathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Transpulmonary pressure
Time Frame: Within 72 hours from the starting of mechanical ventilation
Correlation and agreement between the transpulmonary pressure obtained from esophageal balloon catheter and central venous catheter
Within 72 hours from the starting of mechanical ventilation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Transpulmonary pressure in subgroups of patients
Time Frame: Within 72 hours from the starting of mechanical ventilation
Agreement between trans pulmonary pressure obtained with the two methods in subgroup of patients such as those with acute respiratory distress syndrome or obesity
Within 72 hours from the starting of mechanical ventilation
Transpulmonary pressure in patients at risk for ventilator-induced-lung-injury
Time Frame: Within 72 hours from the starting of mechanical ventilation
Comparison of the transpulmonary pressure obtained with the two methods in patients at risk for ventilator-induced-lung-injury
Within 72 hours from the starting of mechanical ventilation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Federico Franchi, MD, University of Siena, Depatment of Medical Biotechnology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2016

Primary Completion (Actual)

March 1, 2019

Study Completion (Actual)

March 1, 2019

Study Registration Dates

First Submitted

June 1, 2020

First Submitted That Met QC Criteria

June 21, 2020

First Posted (Actual)

June 23, 2020

Study Record Updates

Last Update Posted (Actual)

June 23, 2020

Last Update Submitted That Met QC Criteria

June 21, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome

3
Subscribe